Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Frontiers in Oncology
|
July 29, 2020
Screening Strategies for COVID-19 in Patients With Hematologic Malignancies
Tarek Assi, Bachar Samra, Laurent Dercle, et al.
Hematological Oncology
|
August 12, 2020
Should we screen patients with hematologic malignancies for COVID-19?
Elie Rassy, Rita-Maria Khoury-Abboud, Nathalie Ibrahim, et al.
JCO Global Oncology
|
April 4, 2020
Clinical Characteristics and Outcomes of Caribbean Patients With Adult T-Cell Lymphoma/Leukemia at Two Affiliated New York City Hospitals
Edwin Chiu, Bachar Samra, Eric Tam, et al.
American Journal of Hematology
|
June 6, 2020
Outcome of adults with relapsed/refractory T-cell acute lymphoblastic leukemia or lymphoblastic lymphoma
Bachar Samra, Ahmad S Alotaibi, Nicholas J Short, et al.
Blood Advances
|
August 31, 2021
Long-term outcome of hyper-CVAD-R for Burkitt leukemia/lymphoma and high-grade B-cell lymphoma: focus on CNS relapse
Bachar Samra, Joseph D Khoury, Kiyomi Morita, et al.
Acta Haematologica
|
November 25, 2020
Discontinuation of Maintenance Tyrosine Kinase Inhibitors in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia outside of Transplant
Bachar Samra, Hagop M Kantarjian, Koji Sasaki, et al.
Blood Cancer Journal
|
May 6, 2020
Characteristics and outcomes of patients with therapy-related acute myeloid leukemia with normal karyotype
Bachar Samra, Guillaume Richard-Carpentier, Tapan M Kadia, et al.
Cancer
|
October 29, 2020
Clinical characteristics and outcomes in patients with acute myeloid leukemia with concurrent FLT3-ITD and IDH mutations
Mahran Shoukier, Tapan Kadia, Marina Konopleva, et al.
Cancer
|
April 1, 2021
Prognostic factors for progression in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia in complete molecular response within 3 months of therapy with tyrosine kinase inhibitors
Koji Sasaki, Hagop M Kantarjian, Nicholas J Short, et al.
Blood Cancer Discovery
|
March 8, 2021
Patterns of Resistance Differ in Patients with Acute Myeloid Leukemia Treated with Type I versus Type II FLT3 inhibitors
Ahmad S Alotaibi, Musa Yilmaz, Rashmi Kanagal-Shamanna, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Frontiers in Oncology
|
July 29, 2020
Screening Strategies for COVID-19 in Patients With Hematologic Malignancies
Tarek Assi, Bachar Samra, Laurent Dercle, et al.
Hematological Oncology
|
August 12, 2020
Should we screen patients with hematologic malignancies for COVID-19?
Elie Rassy, Rita-Maria Khoury-Abboud, Nathalie Ibrahim, et al.
JCO Global Oncology
|
April 4, 2020
Clinical Characteristics and Outcomes of Caribbean Patients With Adult T-Cell Lymphoma/Leukemia at Two Affiliated New York City Hospitals
Edwin Chiu, Bachar Samra, Eric Tam, et al.
American Journal of Hematology
|
June 6, 2020
Outcome of adults with relapsed/refractory T-cell acute lymphoblastic leukemia or lymphoblastic lymphoma
Bachar Samra, Ahmad S Alotaibi, Nicholas J Short, et al.
Blood Advances
|
August 31, 2021
Long-term outcome of hyper-CVAD-R for Burkitt leukemia/lymphoma and high-grade B-cell lymphoma: focus on CNS relapse
Bachar Samra, Joseph D Khoury, Kiyomi Morita, et al.
Acta Haematologica
|
November 25, 2020
Discontinuation of Maintenance Tyrosine Kinase Inhibitors in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia outside of Transplant
Bachar Samra, Hagop M Kantarjian, Koji Sasaki, et al.
Blood Cancer Journal
|
May 6, 2020
Characteristics and outcomes of patients with therapy-related acute myeloid leukemia with normal karyotype
Bachar Samra, Guillaume Richard-Carpentier, Tapan M Kadia, et al.
Cancer
|
October 29, 2020
Clinical characteristics and outcomes in patients with acute myeloid leukemia with concurrent FLT3-ITD and IDH mutations
Mahran Shoukier, Tapan Kadia, Marina Konopleva, et al.
Cancer
|
April 1, 2021
Prognostic factors for progression in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia in complete molecular response within 3 months of therapy with tyrosine kinase inhibitors
Koji Sasaki, Hagop M Kantarjian, Nicholas J Short, et al.
Blood Cancer Discovery
|
March 8, 2021
Patterns of Resistance Differ in Patients with Acute Myeloid Leukemia Treated with Type I versus Type II FLT3 inhibitors
Ahmad S Alotaibi, Musa Yilmaz, Rashmi Kanagal-Shamanna, et al.
Page
of 2